Kolon Life Science Inc (102940) — Cash Flow Quality Index
Kolon Life Science Inc (102940) has a Cash Flow Quality Index of 0.10x as of September 2025. Operating cash flow of ₩2.58 Billion is below net income of ₩25.54 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Kolon Life Science Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kolon Life Science Inc Cash Flow Quality Index (2011–2022)
Historical Cash Flow Quality Index for Kolon Life Science Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Kolon Life Science Inc generate cash.
Annual Cash Flow Quality Index for Kolon Life Science Inc (2011–2022)
Year-by-year earnings quality comparison for Kolon Life Science Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -9.78x | ₩-20.85 Billion | ₩2.13 Billion | ▼ -540.4% |
| 2016 | 2.22x | ₩28.11 Billion | ₩12.67 Billion | ▼ -91.5% |
| 2015 | 26.00x | ₩20.81 Billion | ₩800.14 Million | ▲ +1158.9% |
| 2014 | 2.07x | ₩12.10 Billion | ₩5.86 Billion | ▲ +67.1% |
| 2012 | 1.24x | ₩23.37 Billion | ₩18.90 Billion | ▲ +18.5% |
| 2011 | 1.04x | ₩11.65 Billion | ₩11.17 Billion | — |